Adirondack Trust Company’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.2K | Hold |
2,500
| – | – | 0.02% | 242 |
|
|
2025
Q1 | $48.2K | Hold |
2,500
| – | – | 0.02% | 241 |
|
|
2024
Q4 | $44.6K | Hold |
2,500
| – | – | 0.02% | 249 |
|
|
2024
Q3 | $54.7K | Hold |
2,500
| – | – | 0.02% | 237 |
|
|
2024
Q2 | $19.5K | Hold |
2,500
| – | – | 0.01% | 305 |
|
|
2024
Q1 | $10.4K | Hold |
2,500
| – | – | ﹤0.01% | 357 |
|
|
2023
Q4 | $11.3K | Hold |
2,500
| – | – | ﹤0.01% | 344 |
|
|
2023
Q3 | $4.65K | Hold |
2,500
| – | – | ﹤0.01% | 412 |
|
|
2023
Q2 | $5.23K | Hold |
2,500
| – | – | ﹤0.01% | 391 |
|
|
2023
Q1 | $4.38K | Hold |
2,500
| – | – | ﹤0.01% | 410 |
|
|
2022
Q4 | $10.6K | Hold |
2,500
| – | – | 0.01% | 319 |
|
|
2022
Q3 | $3K | Hold |
2,500
| – | – | ﹤0.01% | 431 |
|
|
2022
Q2 | $3K | Hold |
2,500
| – | – | ﹤0.01% | 412 |
|
|
2022
Q1 | $6K | Buy |
2,500
+1,500
| +150% | +$3.6K | ﹤0.01% | 365 |
|
|
2021
Q4 | $3K | Buy |
+1,000
| New | +$3K | ﹤0.01% | 393 |
|